Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.

Naoko HosonoHisayuki YokoyamaNobuyuki AotsukaKiyoshi AndoHiroatsu IidaTakayuki IshikawaKensuke UsukiMasahiro OnozawaMasahiro KizakiKohmei KuboJunya KurodaYukio KobayashiTakayuki ShimizuShigeru ChibaMiho NaraTomoko HataMichihiro HidakaShin-Ichiro FujiwaraYoshinobu MaedaYasuyoshi MoritaMikiko KusanoQiaoyang LuShuichi MiyawakiErhan BerrakNahla HasabouTomoki Naoe

Published in: International journal of clinical oncology (2021)

Findings in Japanese patients are consistent with those of the overall ADMIRAL study population.

Keyphrases

hodgkin lymphoma
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
tyrosine kinase
squamous cell carcinoma
locally advanced
diffuse large b cell lymphoma
multiple myeloma
rectal cancer